Topical Compounded Pain Creams And Pain Perception (TOPCAPP)
Completed
Conditions studied: Pain
In brief
To evaluate the change in patient pain perception with the use of a topical compounded pain cream regimen.
Key facts
- Study ID
- NCT01862848
- Run by
- Medimix Specialty Pharmacy, LLC
- People needed
- 285
- Starts
- 2012-11-01
- Expected to finish
- 2015-06-01
- Last updated by the study team
- 2015-06-15
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participants must be diagnosed with an ICD9 code indicative of chronic pain.
- Participants must be starting a new regimen of topical therapy with multiple compounded agents.
- Participants must be expecting to receive therapy for at least 12 weeks.
- Participants must be between 18 and 65 years of age.
- Participants must be able to provide sound written and verbal informed consent.
You may not qualify if…
- Participants must not have prior hypersensitivity or adverse events to any of the components in the customized prescription.
- Participants must not be pregnant or breastfeeding women.
- Participants must not have a diagnosis of cancer within the past 5 years.
Where it is running
- The Medimix Specialty Pharmacy, LLC — Jacksonville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.